Deep Track Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

Deep Track Capital’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$125M	Buy	3,158,041 +1,158,041	+58%	+$29.6M	2.05%	15
2025 Q4	$50M	Buy	+2,000,000	New	+$50.7M	0.89%	30
2025 Q3	–	Sell	-500,000	Closed	-$6.57M	–	59
2025 Q2	$6.57M	Buy	+500,000	New	+$6.33M	0.21%	48
2025 Q1	–	Sell	-1,350,000	Closed	-$22.6M	–	70
2024 Q4	$22.6M	Hold	1,350,000	–	–	0.84%	33
2024 Q3	$21.6M	Buy	+1,350,000	New	+$16.5M	0.68%	39
2022 Q1	–	Sell	-400,000	Closed	-$4.5M	–	58
2021 Q4	$4.5M	Buy	+400,000	New	+$5.38M	0.32%	49

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Deep Track Capital's CNTA Position: Q1 2026 in Review

Deep Track Capital increased its Centessa Pharmaceuticals (CNTA) stake by 58% in Q1 2026, buying an estimated $29.6M and bringing the position to 3,158,041 shares worth $125M. The position accounts for 2.05% of the portfolio, ranked #15.

Deep Track Capital first reported a position in CNTA in Q4 2021 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

Deep Track Capital held 3,158,041 shares of Centessa Pharmaceuticals worth $125M as of Q1 2026.
Deep Track Capital bought 1,158,041 Centessa Pharmaceuticals shares in Q1 2026, an estimated $29.6M.
Centessa Pharmaceuticals made up 2.05% of Deep Track Capital's portfolio in Q1 2026, its #15 holding.
Deep Track Capital first reported a position in Centessa Pharmaceuticals in Q4 2021 and has held it in 6 quarters since.
161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.